Best Pharmaceutical Stocks

Discover which companies our AI score deems as the best investment opportunities in the pharmaceutical sector, as we rank top pharmaceutical stocks based on a comprehensive data analysis. The AI score combines key financial data and alternative data insights, providing a holistic view of each company's potential and performance.

Company Price Change % AI Score AI Analysis
Tempus AI
Tempus AI
TEM
$35.15 1.2%
75
Generate
Intra-Cellular Therapies
Intra-Cellular Therapies
ITCI
$126.20 0%
74
Generate
Mannkind
Mannkind
MNKD
$6.01 0%
71
Generate
No logo
Sign up to get access
$118.00 0.8%
70
Sign up
No logo
Sign up to get access
$46.52 0.9%
68
Sign up
No logo
Sign up to get access
$71.93 0.7%
68
Sign up
No logo
Sign up to get access
$156.39 0.1%
68
Sign up
No logo
Sign up to get access
$293.64 7.6%
67
Sign up
No logo
Sign up to get access
$11.21 3.4%
66
Sign up
No logo
Sign up to get access
$725.72 4.2%
66
Sign up

According to our AI score, that incorporates fundamental, technical and alternative data analysis, the best stocks in the Pharmaceutical category, are Tempus AI (currently trading at $35.15 with an AI Score of 75) and Intra-Cellular Therapies (currently trading at $126.20 with an AI Score of 74).
Disclaimer: This is not financial advice.

Best Pharmaceutical Stocks Performance

In the last 3 months it's been a good stretch for Pharmaceutical Stocks. Tempus AI is down by -28.8%, Intra-Cellular Therapies is up by 61.1%, Mannkind is down by -8.9%, and Sarepta Therapeutics is down by -7.1%.


FAQ

What Pharmaceutical stock is currently trending?

At the moment, Madrigal Pharmaceuticals has had a nice jump in it stock price. In the past day, the stock is up by 7.6%.

What are the best stocks in the Pharmaceutical category?

The best stocks in the Pharmaceutical category, according to recent data, are Tempus AI (currently trading at $35.15 with an AI Score of 75) and Intra-Cellular Therapies (currently trading at $126.20 with an AI Score of 74). Disclaimer: This is not financial advice. Please do your own research before investing.

What are the best Pharmaceutical stocks to buy today?

The best stocks to buy in the Pharmaceutical category, are Tempus AI (currently trading at $35.15 with an AI Score of 75) and Intra-Cellular Therapies (currently trading at $126.20 with an AI Score of 74). Note that this is investment advice. The information provided is for educational and informational purposes only and should not be construed as financial or investment advice. Conduct your own research or consult a qualified professional before making any investment decisions.

How frequently is the list of best Pharmaceutical stocks updated?

Our price data undergoes updates every 30 minutes to ensure you receive the most recent information. The AI score is updated daily.

How are the best Pharmaceutical stocks determined?

The best pharmaceutical stocks are identified based on the AI score, a dynamic metric calculated using a smart algorithm that analyzes financial, technical, and alternative data.

What is the AI score, and how is it calculated?

The AI score is a unique metric that aggregates insights from various alternative datasets such as revenue, business outlook, webpage traffic, app downloads, and stock sentiment to provide a comprehensive view of a company's standing in the market. It is calculated using advanced algorithms to analyze and weight each dataset appropriately, resulting in a score that can help guide your investment decisions.

Who are the key players in the Pharmaceutical sector?

The Pharmaceutical sector is home to several prominent players. Some of the leading companies include Tempus AI, Intra-Cellular Therapies, Mannkind, among others. Each has its own unique standing in the market, which you can track and list of best stocks above.

How can I get notified when certain Pharmaceutical stocks are trending?

Getting notified when a stock gains momentum is a seamless process on our platform. By signing up, you can activate stock alerts that swiftly bring your attention to stocks that experience an impactful across any of the datasets that we are monitoring. These alerts serve as your proactive guide, ensuring you're always in the loop about emerging trends and conversations, and enabling you to capitalize on potential opportunities as they arise.

About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2025 AltIndex. All rights reserved.